BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29396430)

  • 1. Functional loss of p53 cooperates with the in vivo microenvironment to promote malignant progression of gastric cancers.
    Ohtsuka J; Oshima H; Ezawa I; Abe R; Oshima M; Ohki R
    Sci Rep; 2018 Feb; 8(1):2291. PubMed ID: 29396430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway.
    Oshima H; Matsunaga A; Fujimura T; Tsukamoto T; Taketo MM; Oshima M
    Gastroenterology; 2006 Oct; 131(4):1086-95. PubMed ID: 17030179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer.
    Yamasaki J; Hirata Y; Otsuki Y; Suina K; Saito Y; Masuda K; Okazaki S; Ishimoto T; Saya H; Nagano O
    Cancer Sci; 2022 Mar; 113(3):916-925. PubMed ID: 34931404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of PGE2-associated inflammatory responses in gastric cancer development.
    Oshima H; Oshima M
    Semin Immunopathol; 2013 Mar; 35(2):139-50. PubMed ID: 23053397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis.
    Du YC; Oshima H; Oguma K; Kitamura T; Itadani H; Fujimura T; Piao YS; Yoshimoto T; Minamoto T; Kotani H; Taketo MM; Oshima M
    Gastroenterology; 2009 Oct; 137(4):1346-57. PubMed ID: 19549530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional cooperation of RKTG with p53 in tumorigenesis and epithelial-mesenchymal transition.
    Jiang Y; Xie X; Li Z; Wang Z; Zhang Y; Ling ZQ; Pan Y; Wang Z; Chen Y
    Cancer Res; 2011 Apr; 71(8):2959-68. PubMed ID: 21385899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid Differentiation Factor 88 Signaling in Bone Marrow-Derived Cells Promotes Gastric Tumorigenesis by Generation of Inflammatory Microenvironment.
    Maeda Y; Echizen K; Oshima H; Yu L; Sakulsak N; Hirose O; Yamada Y; Taniguchi T; Jenkins BJ; Saya H; Oshima M
    Cancer Prev Res (Phila); 2016 Mar; 9(3):253-63. PubMed ID: 26888865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
    Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
    Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterization of metastatic gastric cancer cell lines from murine gastric adenocarcinoma lacking Smad4, p53, and E-cadherin.
    Park JW; Park DM; Choi BK; Kwon BS; Seong JK; Green JE; Kim DY; Kim HK
    Mol Carcinog; 2015 Nov; 54(11):1521-7. PubMed ID: 25307412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity.
    Voon DC; Wang H; Koo JK; Nguyen TA; Hor YT; Chu YS; Ito K; Fukamachi H; Chan SL; Thiery JP; Ito Y
    Stem Cells; 2012 Oct; 30(10):2088-99. PubMed ID: 22899304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer.
    Itadani H; Oshima H; Oshima M; Kotani H
    BMC Genomics; 2009 Dec; 10():615. PubMed ID: 20015407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.
    Hosain SB; Khiste SK; Uddin MB; Vorubindi V; Ingram C; Zhang S; Hill RA; Gu X; Liu YY
    Oncotarget; 2016 Sep; 7(37):60575-60592. PubMed ID: 27517620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression and beta-catenin activation in gastric carcinogenesis in N-methyl-N-nitrosourea-treated K19-C2mE transgenic mice.
    Takasu S; Tsukamoto T; Cao XY; Toyoda T; Hirata A; Ban H; Yamamoto M; Sakai H; Yanai T; Masegi T; Oshima M; Tatematsu M
    Cancer Sci; 2008 Dec; 99(12):2356-64. PubMed ID: 19018769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.
    Nakayama M; Sakai E; Echizen K; Yamada Y; Oshima H; Han TS; Ohki R; Fujii S; Ochiai A; Robine S; Voon DC; Tanaka T; Taketo MM; Oshima M
    Oncogene; 2017 Oct; 36(42):5885-5896. PubMed ID: 28628120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant p53 promotes epithelial-mesenchymal plasticity and enhances metastasis in mammary carcinomas of WAP-T mice.
    Lenfert E; Maenz C; Heinlein C; Jannasch K; Schumacher U; Pantel K; Tolstonog GV; Deppert W; Wegwitz F
    Int J Cancer; 2015 Mar; 136(6):E521-33. PubMed ID: 25195563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed cell death 2 protein induces gastric cancer cell growth arrest at the early S phase of the cell cycle and apoptosis in a p53-dependent manner.
    Zhang J; Wei W; Jin HC; Ying RC; Zhu AK; Zhang FJ
    Oncol Rep; 2015 Jan; 33(1):103-10. PubMed ID: 25334010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 regulates epithelial-mesenchymal transition induced by transforming growth factor β.
    Termén S; Tan EJ; Heldin CH; Moustakas A
    J Cell Physiol; 2013 Apr; 228(4):801-13. PubMed ID: 23018556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Runx3-/- gastric epithelial cells differentiate into intestinal type cells.
    Fukamachi H; Ito K; Ito Y
    Biochem Biophys Res Commun; 2004 Aug; 321(1):58-64. PubMed ID: 15358215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes.
    Bessède E; Staedel C; Acuña Amador LA; Nguyen PH; Chambonnier L; Hatakeyama M; Belleannée G; Mégraud F; Varon C
    Oncogene; 2014 Aug; 33(32):4123-31. PubMed ID: 24096479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.